Profile data is unavailable for this security.
About the company
WuXi XDC Cayman Inc is a holding company primarily engaged in the provision of contract research, development and manufacturing services (CRDMO) for antibody drug conjugates (ADCs) and a wider range of bioconjugate drugs. The Company conducts its businesses through two segments. Research Services on Fee-for-service(FFS) Basis segment providing research services to its customers through FFS contracts. The Research Services on Full-time-equivalent(FTE) Basis segment providing a project team of employees dedicated to the customer's studies for a specific period of time. Based on biopharmaceuticals and small molecule drugs, the Company also provides comprehensive cross-domain services, covering the discovery, process development and good manufacturing practice (GMP) production of bioconjugated drugs, linkers and payloads. The Company conducts its business in domestic and foreign markets.
- Revenue in HKD (TTM)3.07bn
- Net income in HKD652.56m
- Incorporated2020
- Employees1.50k
- LocationWuXi XDC Cayman IncNo. 11 Xinhui Ring Road, Xinwu DistrictWUXI KY1-1104ChinaCHN
- Websitehttps://wuxixdc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3SBio Inc | 9.24bn | 1.82bn | 16.31bn | 5.61k | 9.11 | 1.03 | 7.22 | 1.76 | 0.7473 | 0.7473 | 3.79 | 6.59 | 0.3575 | 1.52 | 6.87 | 1,708,233.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
Simcere Pharmaceutical Group Ltd | 6.96bn | -1.21bn | 16.68bn | 6.41k | -- | 2.21 | -- | 2.40 | -0.4626 | -0.4626 | 2.70 | 2.98 | 0.5198 | 2.19 | 2.64 | 990,578.20 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4721 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 17.82bn | 10.78k | 7.29 | 1.13 | 6.20 | 1.68 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
Zai Lab Ltd | 2.51bn | -2.32bn | 18.99bn | 2.18k | -- | 3.42 | -- | 7.57 | -2.39 | -2.39 | 2.58 | 5.58 | 0.3083 | 3.04 | 5.52 | -- | -28.50 | -37.72 | -34.92 | -42.72 | 63.17 | 64.75 | -92.44 | -282.44 | 3.29 | -- | 0.0908 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
The United Laboratories Intl. Hldgs Ltd. | 15.38bn | 3.19bn | 19.91bn | 15.00k | 6.24 | 1.34 | 5.22 | 1.30 | 1.76 | 1.76 | 8.46 | 8.17 | 0.6578 | 3.30 | 5.67 | 1,025,069.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
China Traditional Chinese Med Hldg CoLtd | 18.88bn | 1.01bn | 22.11bn | 17.72k | 21.95 | 0.9425 | 9.63 | 1.17 | 0.20 | 0.20 | 3.75 | 4.66 | 0.453 | 1.54 | 1.82 | 1,091,315.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
China Medical System Holdings Ltd | 7.70bn | 1.53bn | 22.20bn | 5.78k | 14.57 | 1.26 | 12.55 | 2.88 | 0.6246 | 0.6246 | 3.15 | 7.23 | 0.384 | 2.89 | 5.65 | 1,350,396.00 | 7.51 | 18.44 | 8.53 | 21.14 | 74.13 | 75.47 | 19.56 | 34.26 | 3.97 | -- | 0.0667 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
HUTCHMED (China) Ltd | 4.75bn | -326.14m | 27.32bn | 1.97k | -- | 4.75 | -- | 5.76 | -0.3881 | -0.3881 | 5.50 | 6.60 | 0.4775 | 7.10 | 4.15 | 2,387,551.00 | -3.30 | -14.35 | -4.65 | -20.43 | 41.67 | 36.57 | -6.91 | -31.44 | 2.68 | -- | 0.0984 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
WuXi XDC Cayman Inc | 3.07bn | 652.56m | 28.49bn | 1.50k | 44.30 | 4.33 | 38.33 | 9.28 | 0.5361 | 0.5361 | 2.71 | 5.49 | 0.5586 | 21.31 | 2.85 | 2,604,699.00 | 11.88 | -- | 15.43 | -- | 30.96 | -- | 21.27 | -- | 4.02 | -- | 0.0113 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
China Resources Pharmaceutical Group Ltd | 275.00bn | 4.14bn | 37.44bn | 72.76k | 9.04 | 0.7054 | 2.95 | 0.1362 | 0.6595 | 0.6595 | 43.77 | 8.45 | 0.966 | 6.09 | 3.28 | 3,767,792.00 | 3.19 | 3.02 | 12.13 | 11.35 | 15.78 | 15.72 | 3.31 | 2.87 | 1.12 | 11.50 | 0.4396 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
Holder | Shares | % Held |
---|---|---|
Invesco Advisers, Inc.as of 16 Nov 2023 | 37.97m | 3.17% |
UBS Asset Management (Singapore) Ltd.as of 16 Nov 2023 | 15.19m | 1.27% |
UBS Asset Management (Hong Kong) Ltd.as of 28 Jun 2024 | 15.09m | 1.26% |
Capital Research & Management Co. (World Investors)as of 30 Jun 2024 | 9.79m | 0.82% |
Norges Bank Investment Managementas of 31 Dec 2023 | 7.75m | 0.65% |
Fidelity Management & Research (Hong Kong) Ltd.as of 30 Jun 2024 | 5.35m | 0.45% |
Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 5.04m | 0.42% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.41m | 0.20% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 1.17m | 0.10% |
Harvest Global Investments Ltd.as of 31 Dec 2023 | 922.84k | 0.08% |